2020
DOI: 10.1007/s40257-020-00523-1
|View full text |Cite
|
Sign up to set email alerts
|

Topical Minocycline Foam 4%: A Review in Acne Vulgaris

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(18 citation statements)
references
References 16 publications
0
18
0
Order By: Relevance
“…In addition, minocycline lacks immunogenicity and has fluidity and formability, with simple tube sealing operation and easy injection and drug replacement. [ 17 – 19 ]. Moreover, the combined therapy of minocycline plus zinc oxide eugenol cement resulted in a higher treatment efficacy versus minocycline alone, for which several possible explanations are available.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, minocycline lacks immunogenicity and has fluidity and formability, with simple tube sealing operation and easy injection and drug replacement. [ 17 – 19 ]. Moreover, the combined therapy of minocycline plus zinc oxide eugenol cement resulted in a higher treatment efficacy versus minocycline alone, for which several possible explanations are available.…”
Section: Discussionmentioning
confidence: 99%
“…19 Many studies showed that topical minocycline 4% foam was effective at improving acne within 12 weeks; however, a 40 week extension study showed that patients taking this drug continued to show improvement at 52 weeks after treatment. 19,20 Most patients enrolled in clinical trials studying topical minocycline 4% foam tolerated this drug well, with increased creatinine phosphokinase levels and headaches reported as the most common adverse events. 17,18 Topical sodium sulfacetamide is a bacteriostatic antibacterial that functions by halting bacterial DNA synthesis through inhibiting paraaminobenzoic acid.…”
Section: Antibacterial Agentsmentioning
confidence: 99%
“…Amzeeq™, 4% minocycline topical foam, was approved in 2019 by the FDA to treat moderate‐to‐severe, non‐nodular acne in patients older than age 9. This drug is lipophilic and moves through sebum to the pilosebaceous unit 19 . Although the exact mechanism of this drug is not well understood, studies have shown that this agent possesses potent antibacterial effects 19 .…”
Section: Acne Treatmentsmentioning
confidence: 99%
See 2 more Smart Citations